Actively Recruiting
Piloting of an Intervention to Reduce Problematic Alcohol Use in Early Phase Psychosis Patients
Led by Nova Scotia Health Authority · Updated on 2024-08-23
24
Participants Needed
1
Research Sites
212 weeks
Total Duration
On this page
Sponsors
N
Nova Scotia Health Authority
Lead Sponsor
C
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
AI-Summary
What this Trial Is About
A focus of research for youth and Emerging Adults with early phase psychosis (EPP) has been cannabis use. However, this focus has led to overlooking the possible negative influence of another legal recreational drug, alcohol. Previous studies our research group has done have demonstrated that over use of alcohol reduces the effectiveness of early intervention in psychosis treatment services. These treatment services are wrap around services that address medical, and social needs of young people with psychosis. Individuals with alcohol use disorder and EPP have fewer positive symptoms such as hallucinations which are the aspects of psychotic disorders that respond most readily to medication but have greater levels of depressive symptoms. Biologically, we can see the negative impact of alcohol on brain structure in our MRI studies. Our aim presented in this grant is to pilot a psychosocial intervention using cognitive enhancement therapy to reduce alcohol consumption in individuals with early phase psychosis. This intervention has shown promise in reducing alcohol use in individuals with long standing schizophrenia and compare it to treatment as usual which involves brief (1 session) psychoeducation. The investigators hope to reduce substance use in young people in the early stages of a psychotic disorder and improve their odds of a full recovery. In addition to measuring symptoms and hospitalizations, this trial will measure what are called social determinants of health such as return to school or work and resumption of relationships. These variables have not been measured previously in alcohol use interventions in this population but in our experience are the best indicators of long term recovery from psychosis. The symptoms will generally improve with antipsychotic drug treatment but reach a threshold after 6 months in most individuals who engage with our 5 year program. Further functional and social recovery seem to be the best determinants of a full return to health in this population.
CONDITIONS
Official Title
Piloting of an Intervention to Reduce Problematic Alcohol Use in Early Phase Psychosis Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 16 to 35 years
- Enrollment in Early Intervention Services for Psychosis in Nova Scotia
- Psychotic spectrum diagnosis including schizophrenia, schizoaffective disorder, or unspecified schizophrenia spectrum disorder
- Problematic alcohol use defined by a score of 8 or higher on the World Health Organization Alcohol Use Disorders Identification Test (WHO-AUDIT)
- Less than 5 years duration of psychotic illness
You will not qualify if you...
- Presence of any substance use disorder other than nicotine dependence
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Nova Scotia Health Authority
Halifax, Nova Scotia, Canada, B3S0H6
Actively Recruiting
Research Team
C
Candice E Crocker, PhD
CONTACT
P
Philip G Tibbo, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here